Voddu Suresh

4PUBLICATIONS
26CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 29, 2026
KRAS Signaling Inhibition Induces a Targetable Metabolic Dependency on Lipophagy-Dependent Fatty Acid Oxidation in Pancreatic Cancer.

|Mar 28, 2024
The MUC1-HIF-1α signaling axis regulates pancreatic cancer pathogenesis through polyamine metabolism remodeling.

Divya Murthy, Kuldeep S Attri, Voddu Suresh

|Dec 02, 2021
Correction to: Fluvastatin sensitizes pancreatic cancer cells toward radiation therapy and suppresses radiation- and/or TGF-β-induced tumor-associated fibrosis.

Debasish Mohapatra, Biswajit Das, Voddu Suresh

|Nov 13, 2021
Fluvastatin sensitizes pancreatic cancer cells toward radiation therapy and suppresses radiation- and/or TGF-β-induced tumor-associated fibrosis.

Debasish Mohapatra, Biswajit Das, Voddu Suresh

Pageof 1

Frequent Collaborators

2 joint publications

Biswajit Das

2 joint publications

Shantibhusan Senapati

2 joint publications

Girish H Rajacharya

2 joint publications

Pankaj K Singh